CI

At a glance

ClinicalIndex Comparison Record
N/AEnrolling by Invitation· 104 target
Drug / intervention
Behavioral therapy and transcutaneous posterior tibial nerve stimulationother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT07171424
NCT07171424N/AEnrolling by InvitationMonitorUpdated 3mo ago · Completion was 1mo ago
Slow Enrollment
CompareCT.gov

Moving Beyond p-Values: Minimal Clinically Important Difference for Overactive Bladder Questionnaire - Version 8 and International Consultation on Incontinence Questionnaire - Short Form in Patients With Overactive Bladder Syndrome

Artvin Coruh University·interventional·Posted Sep 12, 2025·Updated Mar 17, 2026

In Brief

A clinical study evaluating Behavioral therapy and transcutaneous posterior tibial nerve stimulation for Overactive Bladder Syndrome. Currently enrolling by invitation, targeting 104 participants across 1 site.

Signals

Enrolling slower than its timeline implies

Detailed Summary

The goal of this study was to determine the Minimal Clinically Important Difference (MCID) for the Overactive Bladder Questionnaire-Version 8 (OAB-V8) and the International Consultation on Incontinence Questionnaire- Short Form (ICIQ-SF) in people with Overactive Bladder Syndrome (OAB).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOveractive Bladder Syndrome
CountriesTurkey (Türkiye)
Collaborators--

Timeline

N/AEnrolling by InvitationOverdue
2026
First PostedSep 12, 2025
Enrollment StartJan 1, 2026
Primary CompletionMay 30, 2026
Study CompletionJun 30, 2026
TodayJul 1, 2026
Enrollment to primary: 5 monthsPosted 10 months ago

Interventions

Behavioral therapy and transcutaneous posterior tibial nerve stimulationother

Behavioral therapy included appropriate fluid intake, bladder training, habit training, pelvic floor muscle exercises (Kegel exercises), prompted voiding, and scheduled voiding. TPTNS will be applied in a biphasic square waveform with a frequency of 20 Hz and 200 cycles/sec in 30-minute sessions. The current intensity will be varied between 0.5-20 mA according to the patient's pain threshold.